KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Change in Accured Expenses (2016 - 2025)

Colgate Palmolive (CL) has 17 years of Change in Accured Expenses data on record, last reported at $278.0 million in Q3 2025.

  • For Q3 2025, Change in Accured Expenses rose 109.02% year-over-year to $278.0 million; the TTM value through Sep 2025 reached $219.0 million, down 53.21%, while the annual FY2024 figure was $516.0 million, 66.99% up from the prior year.
  • Change in Accured Expenses reached $278.0 million in Q3 2025 per CL's latest filing, up from -$191.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $278.0 million in Q3 2025 and bottomed at -$191.0 million in Q2 2025.
  • Average Change in Accured Expenses over 5 years is $39.7 million, with a median of $15.0 million recorded in 2023.
  • Peak YoY movement for Change in Accured Expenses: surged 786.67% in 2024, then crashed 812.5% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $121.0 million in 2021, then crashed by 202.48% to -$124.0 million in 2022, then surged by 213.71% to $141.0 million in 2023, then surged by 34.04% to $189.0 million in 2024, then soared by 47.09% to $278.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $278.0 million in Q3 2025, -$191.0 million in Q2 2025, and -$57.0 million in Q1 2025.